Esperion Therapeutics, Inc. (ESPR) Presents at Jefferies London Healthcare Conference 2025 Transcript

Question-and-Answer SessionSo before we kick it off, why don't you make some opening remarks in terms of just the progress over the last several years and importantly, what has happened this year, some of the accomplishments? And then how you're thinking about 2026?Benjamin HalladayChief Financial Officer Yes. There's a lot to unpack with that question. I'll do my best to keep it minimal. So I'll go back to April of 2024 when we received our cardiovascular outcomes trial updated label, which really kind of ...